Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Study Type
OBSERVATIONAL
Enrollment
1,500
Intracept™ Intraosseous Nerve Ablation for treatment of patients diagnosed with vertebrogenic pain
Flagstaff Bone & Joint
Flagstaff, Arizona, United States
Change in Disability (Oswestry Disability Index (ODI) from Baseline
The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.
Time frame: 60-months post-procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Innovative Pain and Wellness
Phoenix, Arizona, United States
RECRUITINGMarinHealth Spine Institute
Larkspur, California, United States
RECRUITINGStanford University Medical Center
Stanford, California, United States
RECRUITINGThe Spine Wellness Center in Westport
Westport, Connecticut, United States
RECRUITINGWashington Hospital Center
Washington D.C., District of Columbia, United States
RECRUITINGOrlando Regional Medical Center
Orlando, Florida, United States
RECRUITINGHorizon Clinical Research, LLC
Jasper, Georgia, United States
RECRUITINGNorth Idaho Day Surgery, LLC
Post Falls, Idaho, United States
WITHDRAWNIllinois Bone and Joint Institute
Barrington, Illinois, United States
RECRUITING...and 12 more locations